OKYO Pharma (FRA:OK10) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:OK10 OKYO Pharma Ltd FRA:OK10
24 GF Score
Price €1.36
! 2 Warning Signs
View Full Analysis

What is OKYO Pharma Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:OK10
24GF Score
OKYO Pharma Ltd FRA:OK10
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OKYO Pharma Business Description

Other Exchanges OKYO:USA
Address 14/15 Conduit Street, Floor 4, London, GBR, W1S 2XJ
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
24GF Score

Get the complete analysis for FRA:OK10

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.36
Price